A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
Completed · Phase 4
Conditions studied: METABOLIC SYNDROME, HYPERTENSION, PRE-HYPERTENSION
In brief
The metabolic syndrome is a classification for patients with a constellation of risk factors which may include abdominal obesity, hypertension, elevated blood lipids and sugar. Three or more of these factors together constitute the metabolic syndrome and place these patients at a greater risk for the development of diabetes and cardiovascular diseases. The purpose of this study is to determine whether two common drugs to lower blood pressure, whether used separately or in combination, have different effects on blood sugar levels in patients diagnosed with the metabolic syndrome.
Key facts
- Study ID
- NCT00170937
- Run by
- Novartis
- People needed
- 507
- Starts
- 2004-11-01
- Last updated by the study team
- 2016-11-18
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Waist circumference: males > 40", females > 35 "
- MSSBP ≥ 130 mmHg but ≤ 160 mmHg and a MSDBP ≥ 85 mmHg but ≤ 100 mmHg
- At least one of the following criteria: - Fasting plasma glucose between 5.9 and 6.9 mmol/L; - Serum triglycerides > 150 mg/dL; - LDL Cholesterol: - < 40 mg/dL males; - < 50 mg/dL females
You may not qualify if…
- MSSBP> 180 mmHg or MSDBP > 110 mmHg
- Inability to discontinue all prior antihypertensives for a period of 4 weeks.
- History of diabetes
- History of stroke, transient ischemic attack or myocardial infarction.
- Significant weight change > 10 lbs during screening period
- Patients taking a diuretic for 3 months prior to screening.
- Other protocol-defined exclusion criteria may apply.
Where it is running
- Novartis Pharmaceuticals — East Hanover, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.